Question explored with the scientific record
Conversation so far
- 1 Does preganalin withdrawal give you night terrors + a private exchange
- 2 Are there safer alternatives for sleep during pregabalin tapering? + a private exchange
- 3 What taper rate is safest to reduce withdrawal insomnia? + a private exchange
- 4 Could this be from withdrawal vs something else like sleep apnea or PTSD?
- 5 Is 75mg a high dose?
Answered on this page ↓
Is 75mg a high dose?
The short version: 75 mg is a low dose of pregabalin, not a high one. It is a starting dose, and the records show it doing little on its own.
The trials here use 75 mg as the floor, not the ceiling. A 2024 back-pain trial ran 75 mg twice daily as its standard arm [1]. A hip surgery trial started at 75 mg twice daily and let people step up to three times daily [3]. A 2021 pain trial dosed pregabalin anywhere from 75 to 600 mg a day [2]. The dose that actually worked in a diabetic nerve pain trial was 300 to 600 mg; 75 mg a day did not beat placebo [6].
| Dose | What the records show |
|---|---|
| 75 mg/day | No better than placebo for nerve pain [6] |
| 75 mg twice daily | Standard trial arm, worked for back pain [1] |
| 150 mg single dose | Sedation, less anxiety before eye surgery [4] |
| 300–600 mg/day | Effective for nerve pain [6] |
| 4200 mg/day | Dependence and a seizure on cold stop [5] |
For your taper, 75 mg is a modest dose to be sitting at, and the records give no reason to think you are stuck at a high level [1][3]. The withdrawal cases at ordinary doses ran from 150 to 600 mg a day [7]. That is the range where a cut can bite, and you are inside it.
My call: 75 mg is a low dose, and the evidence for calling it high is not there. Confidence: moderate, because these are trials in other conditions, not a taper study in you.
Sources used 7
-
Pregabalin versus Gabapentin Efficacy in the Management of Neuropathic Pain Associated with Failed Back Surgery Syndrome
In a 30-day double-blind randomized trial in 60 adults with failed back surgery syndrome, both pregabalin and gabapentin significantly reduced VAS pain, and pregabalin was significantly more effective than gabapentin regardless of gender.
DOI: 10.3340/jkns.2022.0225 -
Treatment Impact on Patient-Reported Outcomes in Peripheral Neuropathic Pain: Comparing Single Intervention With Topical High-Concentration Capsaicin to Daily Oral Pregabalin
A single HCCP intervention improved cognitive functioning, overall health rating, and treatment satisfaction versus daily pregabalin at Week 8 in non-diabetic peripheral neuropathic pain patients, with no significant differences on sleep, utility, or global impression.
DOI: 10.36076/ppj.2021.24.453 -
An Intensive Perioperative Regimen of Pregabalin and Celecoxib Reduces Pain and Improves Physical Function Scores Six Weeks after Total Hip Arthroplasty: A Prospective Randomized Controlled Trial
In a small underpowered randomized trial, pregabalin plus celecoxib started two weeks before total hip arthroplasty improved pain and WOMAC function at six weeks, but the primary 6 min walk test outcome did not differ.
DOI: 10.1155/2013/258714 -
Perioperative Anxiolytic and Analgesic Effects of Pregabalin in Vitreo-Retinal Surgery: A Randomized, Double-blind Study
In a randomized double-blind trial, pregabalin 150 mg before vitrectomy under peribulbar block improved sedation, reduced anxiety and block-placement pain, improved patient cooperation and satisfaction, and reduced rescue midazolam and postoperative analgesia versus placebo.
DOI: 10.5812/aapm.117414 -
SEİZURE TRİGGERED BY SUDDEN DİSCONTİNUATİON OF PREGABALİN: A CASE REPORT
A 24-year-old male with pregabalin dependence and no history of epilepsy developed a generalized tonic-clonic seizure three days after abruptly discontinuing chronic high-dose (4200 mg/day) pregabalin, with all investigations (labs, MRI, EEG) normal, and no seizure recurrence af…
DOI: 10.70846/nigdetip.1813909 -
Pregabalin for Pain Management
Pregabalin, an alpha-2-delta calcium-channel ligand, reduces neuropathic pain and improves sleep in postherpetic neuralgia and diabetic peripheral neuropathy, with dizziness and somnolence as common dose-related adverse effects.
DOI: 10.1111/j.1533-2500.2005.05205.x -
Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review
Three patients without psychiatric or substance-use disorders developed withdrawal symptoms after abrupt reduction or discontinuation of regular-dose pregabalin, and symptoms improved after resuming pregabalin; a literature review found six similar published cases.
DOI: 10.1002/npr2.12195